patents

Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Mon, 02/20/17 - 10:07 am
Amgen
patents
BPCIA
FDA
Sandoz
Neupogen
generics
Genentech
Avastin
The CRISPR patent decision: Your six takeaways
Stat
Thu, 02/16/17 - 10:13 am
CRISPR Therapeutics
patents
CRISPR-Cas9
Broad Institute
Teva Confirms Generic Victoza® Patent Challenge in the United States
Yahoo
Thu, 02/2/17 - 09:20 am
Teva Pharmaceutical
patents
diabetes
Victoza
generics
Novo Nordisk
Are Teva Pharmaceutical's Best Days Behind It?
Motley Fool
Wed, 02/1/17 - 05:36 pm
Teva Pharmaceutical
Copaxone
generics
patents
MS
multiple sclerosis
Merck Makes Nice With Bristol-Myers Squibb
Motley Fool
Tue, 01/31/17 - 10:07 am
Merck
Bristol-Myers Squibb
patents
Keytruda
Opdivo
Teva shares fall as court invalidates patent infringement claims
Marketwatch
Mon, 01/30/17 - 10:51 pm
Teva Pharmaceutical
patents
Copaxone
Mylan Labs
multiple sclerosis
MS
Novartis says court battle will delay its Enbrel copy until 2018 at least
Yahoo/Reuters
Wed, 01/25/17 - 09:58 am
Novartis
Enbrel
patents
Erelzi
Amgen
biosimilars
rheumatoid arthritis
Merck to pony up $625M plus Keytruda royalties to settle BMS, Ono patent fight
Fierce Pharma
Mon, 01/23/17 - 11:11 am
Merck
Keytruda
Bristol-Myers Squibb
Ono Pharmaceutical
Opdivo
patents
Why Patent Protection In The Drug Industry Is Out Of Control
Forbes
Thu, 01/19/17 - 11:31 am
patents
Biogen to pay $1.25B settlement in multiple sclerosis drug case
Bizjournals.com
Tue, 01/17/17 - 11:09 am
Biogen
Tecfidera
Forward Pharma
MS
multiple sclerosis
patents
The Top 5 Drug Patents Expiring in 2017
Investopedia
Mon, 01/16/17 - 11:48 am
patents
Novartis
Eli Lilly
Merck
Bristol-Myers Squibb
Sandostatin LAR
Cubicin
Reyataz
Vytorin
Strattera
Lilly Jumps After Lung Cancer Drug Patent Upheld
Bloomberg
Fri, 01/13/17 - 11:26 am
Eli Lilly
patents
Alimta
lung cancer
Teva Pharmaceutical
Why Novartis Dropped 15.1% in 2016
Motley Fool
Wed, 01/11/17 - 10:00 am
Novartis
Gleevec
Diovan
patents
generics
Regeneron CEO says Amgen not putting patients first in patent dispute
Yahoo/Reuters
Tue, 01/10/17 - 09:19 am
Regeneron
Pharma CEOs
Amgen
Sanofi
patents
Repatha
Praluent
Len Schleifer
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection
Yahoo
Fri, 01/6/17 - 10:22 am
Regeneron
Sanofi
Amgen
patents
Repatha
Praluent
Amgen Wins Ban on Sanofi’s Praluent Cholesterol Drug Sales
Bloomberg
Fri, 01/6/17 - 09:51 am
Amgen
Sanofi
Regeneron
Praluent
Repatha
patents
The 3 Biggest Risks for Pfizer in 2017
Motley Fool
Tue, 12/27/16 - 10:29 am
Pfizer
Xtandi
competition
patents
Lyrica
Celebrex
Juno Therapeutics Defeats Kite Pharma’s Challenge to CAR T-Cell Patent
Yahoo
Mon, 12/19/16 - 11:41 am
Juno Therapeutics
Kite Pharma
CAR-T
patents
Gilead’s Patent Loss to Merck Started With a Broken Friendship
Bloomberg
Mon, 12/19/16 - 10:55 am
Gilead Sciences
Merck
patents
hepatitis C
Sovaldi
Harvoni
Merck Wins Record $2.5 Billion Patent Verdict Against Gilead
Bloomberg
Fri, 12/16/16 - 09:51 am
Merck
patents
Gilead Sciences
hepatitis C
Harvoni
Sovaldi

Pages